Look carefully at HSCS that kiwi appears to like. With Bhatt, Futterer and Icahn School of Medicine(Icahn Mount Sinai) aboard with an equity investment in HSCS resulting from the licensing of the incipient AI-driven technology to be developed, competition with CDIO may well develop.
I kept our shares of CDIO and bought 10k shares of HSCS in AH tonight at $0.1886.
HSCS may currently be months behind CDIO in obtaining an approved 510(k) application from FDA.
lizzy241, looks like there are approximately 18M total outstanding CDIO shares that traded back and forth yesterday for 138,466M total. Is this correct?
News 
Market Data 
Discover 
